Long noncoding RNA SNHG4: a novel target in human diseases.

Abstract

Recently, long noncoding RNAs (lncRNAs) have attracted great attention from researchers. LncRNAs are non-protein-coding RNAs of more than 200 nucleotides in length. Multiple studies have been published on the relationship between lncRNA expression and the progression of human diseases. LncRNA small nucleolar RNA host gene 4 (SNHG4), a member of the lncRNA SNHG family, is abnormally expressed in a variety of human diseases, including gastric cancer, renal cell carcinoma, glioblastoma, neuroblastoma, prostate cancer, colorectal cancer, osteosarcoma, cervical cancer, liver cancer, lung cancer, non-small-cell lung cancer, neonatal pneumonia, diabetic retinopathy, neuropathic pain, acute cerebral infarction, acute myeloid leukaemia, and endometriosis. In this paper, the structure of SNHG4 is first introduced, and then studies in humans, animal models and cells are summarized to highlight the expression and function of SNHG4 in the above diseases. In addition, the specific mechanism of SNHG4 as a competing endogenous RNA (ceRNA) is discussed. The findings indicate that SNHG4 can be used as a biomarker for disease prognosis evaluation and as a potential target for disease diagnosis and treatment.

• Authors: Qingfei Chu, Xinyu Gu, Qiuxian Zheng, Zixuan Guo, Dandan Shan, Jing Wang, Haihong Zhu
• Journal: Cancer cell international (Cancer Cell Int) Vol. 21 Issue 1 Pg. 583 (Oct 30 2021) ISSN: 1475-2867 [Print] England
• PMID: 34717631 (Publication Type: Journal Article, Review)
• Copyright: © 2021. The Author(s).